Study S001524

Effects of Liraglutide on Left Ventricular Function in Patients With Non-ST-Segment Elevation Myocardial Infarction

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02577848
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: DOUBLE
Status: UNKNOWN
Enrollment: 90
Start: 2015-10
Primary completion: 2016-10
Lead sponsor: Chinese PLA General Hospital
Conditions: Myocardial Infarction
Interventions: DRUG:GLP-1; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

left ventricular ejection fractions [at 3 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0023502	Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Lønborg J, European heart journal	2012	Randomized trial	PMID 21920963 DOI	registry reference BACKGROUND:21920963